Key clinical Research

Listed below are the different ongoing projects in the laboratory :

1. Study of the scientific rationale for combination therapy of the selective SGLT2 inhibitor dapagliflozin and GLP-1 analog to improve glycemic control.

2. Optimization of pancreatic islet transplantation by ex vivo hypothermic infusion of human pancreas.

3. Involvement of Treg Autoimmune Reactivation of Type 1 Diabetes After Clinical Islet Transplantation.

4. Regulation of lysosomal function by nutrients in type 2 diabetes.

5. Combination of low dose sulfonylureas with the SGLT2 inhibitor dapagliflozin to improve glycaemic control.

6. Role of intestine in type 2 diabetes remission after gastric By-Pass surgery.

7. Pilot study about glucidic tolerance in patients with pancreatic slow malignant tumor.

SPONSORS websites :

  1. ABM :
  2. ANR :
  3. ARD :
  4. EFSD :
  5. FFRD :
  6. Santélys :